Arrow International
Arrow International reports earnings of $0.28 per share
Published in Cardiovascular Business Week, May 2nd, 2006
Net sales for the second quarter of fiscal year 2006 increased to $116.5 million from $109.2 million in the second quarter of fiscal year 2005.
Operating income increased to $18.1 million from $7.1 million primarily due to recognition in the second quarter of fiscal 2005 of $6.8 million in expenses due to the company's voluntary early retirement program, and $4.9 million of charges related to the discontinuance of the company's Arrow LionHeart Left Ventricular Assist Program.
Impacting operating income for the...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Cardiovascular Business Week
More Articles from Cardiovascular Business Week
- Chemokine Therapeutics
Chemokine Therapeutics incurs net loss of $6 million for 2005 - Finance
Anthem Blue Cross and Blue Shield in Virginia awards $12M to 41 hospitals - PharmaFrontiers Corp.
PharmaFrontiers reports net loss for the full year 2005 was $19.4 million - RegeneRx Biopharmaceuticals, Inc.
RegeneRx reports net loss of $5.5 million - Roche
Roche Foundation for Anaemia Research to award new grant worth over US$1.8 million - Sorin Group
Sorin Group's 2005 results show profitability up sharply, restructuring bringing benefits - More from this issue of Cardiovascular Business Week
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
